WAYNE, Pa., Sept. 17, 2013 /PRNewswire/ -- Ryan & Maniskas, LLP is investigating potential claims against the board of directors of Cornerstone Therapeutics Inc. ("Cornerstone" or the "Company") (NASDAQ: CRTX) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to Chiesi Farmaceutici S.p.A. in a transaction valued at approximately $107 million.
Under the terms of the agreement, shareholders of Cornerstone will receive $9.50 per share in cash for each share of Cornerstone they own.
If you own shares of Cornerstone and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or to sign up online, visit: www.rmclasslaw.com/cases/crtx. You may also email Mr. Maniskas at firstname.lastname@example.org.Our investigation concerns possible breaches of fiduciary duty and other violations of state law by Cornerstone's Board of Directors for not acting in the Company's shareholders' best interests in connection with the sale process. Ryan & Maniskas, LLP is a national shareholder litigation firm. Ryan & Maniskas, LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide. To learn more about the class action process, please visit: www.rmclasslaw.com. CONTACT: Ryan & Maniskas, LLP Richard A. Maniskas, Esquire 995 Old Eagle School Rd., Suite 311 Wayne, PA 19087 877-316-3218 www.rmclasslaw.com/cases/crtx email@example.com SOURCE Ryan & Maniskas, LLP
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts